Financial statements Pharmamax
Balance sheet of Pharmamax
Company age:
Age:
7 y. 11 m. 20 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of PHARMAMAX
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 73 146,10 | 362 652,96 | 570 062,32 | 568 330,42 | 578 065,92 | 798 403,82 |
| A. Fixed assets | 6 208,44 | 125 602,03 | 139 273,20 | 114 041,78 | 101 121,01 | 96 602,03 |
| B. Current assets | 66 937,66 | 237 050,93 | 430 789,12 | 454 288,64 | 476 944,91 | 701 801,79 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | 0,00 |
| D. Own shares (stocks) | - | - | - | - | - | 0,00 |
| Total liabilities | 73 146,10 | 362 652,96 | 570 062,32 | 568 330,42 | 578 065,92 | 798 403,82 |
| A. Equity | -41 219,82 | -278 719,24 | -49 063,51 | -222 094,53 | -451 387,79 | -525 346,78 |
| B. Liabilities and provisions for liabilities | 114 365,92 | 641 372,20 | 619 125,83 | 790 424,95 | 1 029 453,71 | 1 321 577,22 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 | - |
| II. Short-term liabilities | - | 443 073,47 | 395 176,34 | 393 445,44 | 634 947,97 | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.